{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:47:52Z","timestamp":1788742072000,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["5480 &amp; 7972"],"award-info":[{"award-number":["5480 &amp; 7972"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002349","name":"Academy of Scientific Research and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","award":["1\/143\/42"],"award-info":[{"award-number":["1\/143\/42"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jmgm.2021.107904","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T19:16:00Z","timestamp":1616267760000},"page":"107904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4819-2040","authenticated-orcid":false,"given":"Mahmoud A.A.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eslam A.R.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa H.M.","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6486-9835","authenticated-orcid":false,"given":"Khaled S.","family":"Allemailem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5509-9875","authenticated-orcid":false,"given":"Mahmoud F.","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Shawky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mahzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahim Refdan","family":"Hakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8667-664X","authenticated-orcid":false,"given":"Khlood A.A.","family":"Abdeljawaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2462-1269","authenticated-orcid":false,"given":"Mohamed A.M.","family":"Atia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2021.107904_bib1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health \u2014 the latest 2019 novel coronavirus outbreak in Wuhan, China","volume":"91","author":"Hui","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jmgm.2021.107904_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A\u00a0new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2021.107904_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jinf.2020.02.016","article-title":"Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China","volume":"80","author":"Yang","year":"2020","journal-title":"J.\u00a0Infect."},{"key":"10.1016\/j.jmgm.2021.107904_bib6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/d41587-020-00003-1","article-title":"Coronavirus puts drug repurposing on the fast track","volume":"38","author":"Harrison","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jmgm.2021.107904_bib7","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jama.2020.16349","article-title":"Effect of remdesivir vs standard care on clinical status at 11 Days in patients with moderate COVID-19 A randomized clinical trial","volume":"324","author":"Spinner","year":"2020","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.jmgm.2021.107904_bib8","article-title":"Dexamethasone in hospitalized patients with covid-19 - preliminary report","author":"Group","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jmgm.2021.107904_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/S2589-7500(20)30086-8","article-title":"A\u00a0real-time dashboard of clinical trials for COVID-19","author":"Thorlund","year":"2020","journal-title":"Lancet Digit. Health"},{"key":"10.1016\/j.jmgm.2021.107904_bib10","series-title":"DRAFT Landscape of COVID-19 Candidate Vaccines","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.jmgm.2021.107904_bib11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmgm.2021.107904_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2021.107904_bib13","first-page":"1","article-title":"In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors","author":"Ibrahim","year":"2020","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2021.107904_bib14","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.3390\/molecules25173830","article-title":"Drug repurposing for candidate SARS-CoV-2 main protease inhibitors by a novel in silico method","volume":"25","author":"Sencanski","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2021.107904_bib15","series-title":"Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors, Protein J","author":"Ibrahim","year":"2021"},{"key":"10.1016\/j.jmgm.2021.107904_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/md18040225","article-title":"Putative inhibitors of SARS-CoV-2 main protease from A library of marine natural products: a virtual screening and molecular modeling study","volume":"18","author":"Gentile","year":"2020","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.jmgm.2021.107904_bib17","first-page":"1","article-title":"Natural-like products as potential SARS-CoV-2 M(pro) inhibitors: in-silico drug discovery","author":"Ibrahim","year":"2020","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2021.107904_bib18","first-page":"104046","article-title":"In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors, Comput","volume":"126","author":"Ibrahim","year":"2020","journal-title":"Biol. Med."},{"key":"10.1016\/j.jmgm.2021.107904_bib19","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1007\/s00705-017-3417-y","article-title":"Flavonoids: promising natural compounds against viral infections","volume":"162","author":"Zakaryan","year":"2017","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jmgm.2021.107904_bib20","doi-asserted-by":"crossref","first-page":"e0240653","DOI":"10.1371\/journal.pone.0240653","article-title":"Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: a molecular docking and simulation studies","volume":"15","author":"Cherrak","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.jmgm.2021.107904_bib21","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1080\/14756366.2020.1801672","article-title":"Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro","volume":"35","author":"Jo","year":"2020","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.jmgm.2021.107904_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jsps.2016.04.025","article-title":"The pharmacological potential of rutin","volume":"25","author":"Ganeshpurkar","year":"2017","journal-title":"Saudi Pharmaceut. J."},{"key":"10.1016\/j.jmgm.2021.107904_bib23","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1080\/07391102.2012.736774","article-title":"Structural insights into the South African HIV-1 subtype C protease: impact of hinge region dynamics and flap flexibility in drug resistance","volume":"31","author":"Naicker","year":"2013","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2021.107904_bib24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.antiviral.2007.03.008","article-title":"In\u00a0vitro anti-HIV and -HSV activity and safety of sodium rutin sulfate as a microbicide candidate","volume":"75","author":"Tao","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jmgm.2021.107904_bib25","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/BF02978215","article-title":"Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in\u00a0vitro","volume":"28","author":"Lyu","year":"2005","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.jmgm.2021.107904_bib26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.micres.2009.09.002","article-title":"Antibacterial, antifungal, and antiviral activities of some flavonoids","volume":"165","author":"Orhan","year":"2010","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.jmgm.2021.107904_bib27","first-page":"1","article-title":"In-Silico approach for identification of effective and stable inhibitors for COVID-19 main protease (M(pro)) from flavonoid based phytochemical constituents of Calendula officinalis","author":"Das","year":"2020","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2021.107904_bib28","first-page":"1","article-title":"In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19","author":"Chikhale","year":"2020","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2021.107904_bib29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2217\/fvl-2020-0099","article-title":"Possible SARS-coronavirus 2 inhibitor revealed by simulated molecular docking to viral main protease and host toll-like receptor","volume":"15","author":"Hu","year":"2020","journal-title":"Future Virol."},{"key":"10.1016\/j.jmgm.2021.107904_bib30","doi-asserted-by":"crossref","first-page":"25335","DOI":"10.1039\/D0CP03867A","article-title":"Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2\u2019s main protease","volume":"22","author":"Huynh","year":"2020","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.jmgm.2021.107904_bib31","doi-asserted-by":"crossref","first-page":"W368","DOI":"10.1093\/nar\/gki464","article-title":"H++: a server for estimating pKas and adding missing hydrogens to macromolecules","volume":"33","author":"Gordon","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2021.107904_bib32","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/ci100031x","article-title":"Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database","volume":"50","author":"Hawkins","year":"2010","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2021.107904_bib33","series-title":"OMEGA 2.5.1.4","year":"2013"},{"key":"10.1016\/j.jmgm.2021.107904_bib34","series-title":"SZYBKI 1.9.0.3","year":"2016"},{"key":"10.1016\/j.jmgm.2021.107904_bib35","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X","article-title":"MMFF VI. MMFF94s option for energy minimization studies","volume":"20","author":"Halgren","year":"1999","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2021.107904_bib36","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2021.107904_bib37","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nprot.2016.051","article-title":"Computational protein-ligand docking and virtual drug screening with the AutoDock suite","volume":"11","author":"Forli","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jmgm.2021.107904_bib38","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/0040-4020(80)80168-2","article-title":"Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges","volume":"36","author":"Gasteiger","year":"1980","journal-title":"Tetrahedron"},{"key":"10.1016\/j.jmgm.2021.107904_bib39","series-title":"AMBER","author":"Case","year":"2016"},{"key":"10.1016\/j.jmgm.2021.107904_bib40","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2021.107904_bib41","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2021.107904_bib42","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jcc.10128","article-title":"Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation","volume":"23","author":"Jakalian","year":"2002","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2021.107904_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-4622(98)00226-9","article-title":"Implicit solvent models","volume":"78","author":"Roux","year":"1999","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.jmgm.2021.107904_bib44","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1021\/j100142a004","article-title":"A\u00a0well-behaved electrostatic potential based method using charge restraints for deriving atomic charges - the RESP model","volume":"97","author":"Bayly","year":"1993","journal-title":"J.\u00a0Phys. Chem."},{"key":"10.1016\/j.jmgm.2021.107904_bib45","series-title":"Gaussian 09","author":"Frisch","year":"2009"},{"key":"10.1016\/j.jmgm.2021.107904_bib46","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.jmgm.2021.107904_bib47","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: AnN\u22c5log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.jmgm.2021.107904_bib48","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular-dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.jmgm.2021.107904_bib49","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/jcc.540130805","article-title":"Settle - an analytical version of the shake and rattle algorithm for rigid water models","volume":"13","author":"Miyamoto","year":"1992","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2021.107904_bib50","series-title":"Syst\u00e8mes BIOVIA, Version 2019","author":"Dassault","year":"2019"},{"key":"10.1016\/j.jmgm.2021.107904_bib51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1008763014207","article-title":"Combined molecular mechanical and continuum solvent approach (MM-PBSA\/GBSA) to predict ligand binding","volume":"18","author":"Massova","year":"2000","journal-title":"Perspect. Drug Discov. Des."},{"key":"10.1016\/j.jmgm.2021.107904_bib52","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1023\/A:1020444330011","article-title":"Rate-limited steps of human oral absorption and QSAR studies","volume":"19","author":"Zhao","year":"2002","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.jmgm.2021.107904_bib53","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nrd941","article-title":"Integration of virtual and high-throughput screening","volume":"1","author":"Bajorath","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jmgm.2021.107904_bib54","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1021\/acs.jmedchem.5b01684","article-title":"Role of molecular dynamics and related methods in drug discovery","volume":"59","author":"De Vivo","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jmgm.2021.107904_bib55","series-title":"Silico Models for Drug Discovery","first-page":"95","article-title":"Molecular dynamics simulations in drug design","author":"Kerrigan","year":"2013"},{"key":"10.1016\/j.jmgm.2021.107904_bib56","first-page":"777","article-title":"Re-assessing the rule of 5, two decades on","volume":"17","author":"Mullard","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jmgm.2021.107904_bib57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijid.2020.05.085","article-title":"Lack of antiviral activity of darunavir against SARS-CoV-2","volume":"97","author":"De Meyer","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jmgm.2021.107904_bib58","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41401-020-0483-6","article-title":"Anti-SARS-CoV-2 activities in\u00a0vitro of Shuanghuanglian preparations and bioactive ingredients","volume":"41","author":"Su","year":"2020","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326321000735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326321000735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:37:42Z","timestamp":1778798262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326321000735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":56,"alternative-id":["S1093326321000735"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2021.107904","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2021.107904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107904"}}